• Azacitidine Seacross 25 mg/ml powder for injectable suspension EFG

  Form: powder for injectable suspension

  Active substance	Dosage
  AZACITIDINE	100 mg

  ATC: L01B L01BC L01BC07

• Cyclophosphamide Seacross 1.000 mg powder for injection and for infusion EFG

  Form: powder for injectable solution and for perfusion

  Active substance	Dosage
  CYCLOPHOSPHAMIDE MONOHYDRATE	1.069 mg

  ATC: L01A L01AA L01AA01

• Cyclophosphamide Seacross 500 mg powder for injection and for infusion EFG

  Form: powder for injectable solution and for perfusion

  Active substance	Dosage
  CYCLOPHOSPHAMIDE MONOHYDRATE	534,5 mg

  ATC: L01A L01AA L01AA01

• Docetaxel Seacross 20 mg/ml concentrate for solution for infusion EFG

  Form: solution for infusion, concentrate

  Active substance	Dosage
  DOCETAXEL	20 mg

  ATC: L01C L01CD L01CD02

• Plerixafor Seacross 20 mg/ml solution for injection EFG

  Form: solution for injection

  Active substance	Dosage
  PLERIXAFOR	20 mg/ml

  ATC: L03A L03AX L03AX16

• Thiotepa SeaCross 15 mg powder for concentrate for solution for infusion EFG

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TIOTEPA	15 mg

  ATC: L01A L01AC L01AC01

• Thiotepa Seacross 100 mg powder for concentrate for solution for infusion EFG

  Form: powder for concentrate for solution for infusion

  Active substance	Dosage
  TIOTEPA	100 mg

  ATC: L01A L01AC L01AC01

• Valproic acid Seacross 100 mg/ml solution for injection and infusion

  Form: solution for injection and for infusion

  Active substance	Dosage
  SODIUM VALPROATE	100 mg/ml

  ATC: N03A N03AG N03AG01

• Voriconazole Seacross 200 mg powder for solution for infusion EFG

  Form: powder for solution for infusion

  Active substance	Dosage
  VORICONAZOLE	200 mg

  ATC: J02A J02AC J02AC03

• Zoledronic acid Seacross 5 mg/100 ml solution for infusion EFG

  Form: solution for infusion

  Active substance	Dosage
  ZOLEDRONIC ACID MONOHYDRATE	0,0533 mg/ml

  ATC: M05B M05BA M05BA08